Home / Stocks / NORRIS
Back to all stocks
BSE · NORRIS

Norris Medicines Ltd. (NORRIS) Share Price

Sector: Healthcare · ISIN: INE744C01029

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,370
of 5,047 stocks
▼ 451W▼ 571M
Peak #4,154 · 21 Sep 2026

Norris Medicines Ltd., a microcap Healthcare business, is growing revenue modestly, posts a modest return on equity, and has promoters holding 34%. Ownership as of Jun 2026.

Market Cap
14.00 Cr
P/E Ratio
—
P/B Ratio
—
ROE
8.32%
ROCE
-20.18%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ1 2026-27Q3 2025-26Q1 2025-26Q4 2024-25
Revenue92.49 L3.27 Cr1.46 Cr2.72 Cr
Net Profit-39.68 L69.74 L-31.04 L-22.85 L
EPS-0.400.70-0.31-0.23
Operating Profit-39.67 L82.33 L-19.89 L-2.36 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
34.01%
Public
65.99%

PUBLIC BREAKDOWN

DII
0.07%
MF (within DII)
0.01%
Individuals
21.16%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-DateTypeDetails
22 Aug 2013OtherConsolidation of Shares
22 Aug 2013OtherReduction of Capital

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs